CAPRELSA (Vandetinib) Tablets


What is Caprelsa (Vandetinib)

Caprelsa (INN, trade name Caprelsa) is an anti-cancer drug that is used for the treatment of certain tumours of thyroid gland

CAPRELSA

Drug Manufacturer / Marketeer :

M/s AstraZenica


Available as:

100 MG & 300 MG TABLETS.

Indications:
Caprelsa is indicated for treatment of symptomatic or medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.

Treatment:
For treatment related information, please consult your treating Physician.

How supplied:

    • Caprelsa 100 mg available in bottles containing 30 Tablets.
    • Caprelsa 300 mg available in bottles containing 30 Tablets.

Storage and handling:
Store at 20°- 25° C, excursions permitted to 15° to 30° C.

How do we source the Drug?
SMIQ Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is also essential.

Company that Manufactures/ Markets:
M/s AstraZenica

Assistance Cell in India:
For ONCOLOGY DRUG: CAPRELSA (Vandetinib) Tablets 100MG & 300MG price.

Contact us @ +91 7678048225 or by email  info@smiqpharma.com.